Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
2
×
ipo
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
2
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
brainvectis
bristol-myers squibb
What
ipo
2
×
new
2
×
activity
approvals
bio
biogen
biotechs
clamped
club
companies
continued
covid
crop
delays
developing
economic
exceeded
fast
fda
firms
group
haul
including
isn’t
joined
latest
life
lot
medicines
met
million
momentum
nasdaq
neon
offerings
oric’s
positive
projections
public
raised
Language
unset
Current search:
new
×
cancer
×
" indiana top stories "
×
photo
×
" raleigh-durham blog main "
×
ipo
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M